New research will help predict, treat, long-lasting, debilitating migraines

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

HARTFORD — Dr. Brian Grosberg, medical director of the Hartford HealthCare Headache Program, was awarded the first-ever Migraine Research Foundation “Impact” Award. This $250,000 grant will fund leading-edge research on status migrainosus, a severe form of migraine that lasts longer than three days.

Grosberg shares the award with Harvard Medical School’s Dr. Rami Burstein. The two internationally known headache specialists will use the award to study long-lasting migraines that have no clear-cut, documented evidence-based treatment. Until now, many were treated with different drugs—that clinicians choose using trial and error.

This becomes the first scientific study that will delve into patients and their specific characteristics so science can better predict how to treat and even prevent this kind of migraine. This critical project could have an enormous impact on migraine sufferers and lead to better, more effective and more personalized treatment for all status migrainosus patients.